Portland, OR, June 27, 2022 (GLOBE NEWSWIRE) — As per the report published by Allied Market Research, the global transdermal drug delivery systems market generated $52.47 billion in 2020, and is expected to reach $87.32 billion by 2030, growing at a CAGR of 4.9% from 2021 to 2030.
Increase in global population & geriatric medicine and rise in number of patients suffering from chronic diseases including heart diseases, arthritis, and diabetes have boosted the growth of the global transdermal drug delivery systems market. In addition, advancements in transdermal drug delivery systems would open new opportunities in the future.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/485
Covid-19 scenario:
- The Covid-19 pandemic negatively impacted the market due to prolonged lockdown. However, the pandemic increased the importance of government healthcare facilities and healthcare spending across the globe.
- Decrease in number of Covid-19 cases led to reopening of transdermal drug delivery system research facilities, which will help the market get back on track.
Get detailed COVID-19 impact analysis on the Transdermal Drug Delivery Systems Market- https://www.alliedmarketresearch.com/request-for-customization/485?reqfor=covid
The report segments the global transdermal drug delivery systems market on the basis of type of delivery system, application, and region.
Based on type of delivery system, the passive segment held the…
